News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,457 Results
Type
Article (58424)
Company Profile (216)
Press Release (586805)
Multimedia
Podcasts (173)
Webinars (24)
Section
Business (165705)
Career Advice (2487)
Deals (30578)
Drug Delivery (168)
Drug Development (79065)
Employer Resources (162)
FDA (16771)
Job Trends (13696)
News (299956)
Policy (32218)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2648)
Academic (1)
Accelerated approval (58)
ADA (44)
Adcomms (42)
Allergies (196)
Alliances (42547)
ALS (221)
Alzheimer's disease (1891)
Antibody-drug conjugate (ADC) (550)
Approvals (17101)
Artificial intelligence (719)
ASCO (344)
Autoimmune disease (340)
Automation (53)
Bankruptcy (325)
Best Places to Work (10604)
BIOSECURE Act (23)
Biosimilars (237)
Biotechnology (150)
Bladder cancer (211)
Brain cancer (83)
Breast cancer (841)
Cancer (6606)
Cardiovascular disease (515)
Career advice (2122)
Career pathing (48)
CAR-T (372)
CDC (76)
Celiac Disease (2)
Cell therapy (996)
Cervical cancer (56)
Clinical research (68833)
Collaboration (2097)
Commercialization (1)
Company closure (7)
Compensation (1503)
Complete response letters (105)
COVID-19 (2847)
CRISPR (116)
C-suite (1183)
Cystic fibrosis (158)
Data (8441)
Decentralized trials (3)
Denatured (41)
Depression (187)
Dermatology (96)
Diabetes (643)
Diagnostics (6685)
Digital health (55)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (340)
Drug pricing (240)
Drug shortages (35)
Duchenne muscular dystrophy (315)
Earnings (70230)
Editorial (79)
Employer branding (20)
Employer resources (144)
Events (99820)
Executive appointments (1071)
FDA (20736)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (33)
Funding (1742)
Gene editing (247)
Generative AI (62)
Gene therapy (791)
GLP-1 (1204)
Government (4737)
Grass and pollen (8)
Guidances (413)
Healthcare (17515)
Hematology (190)
HIV (95)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (115)
Immunology and inflammation (343)
Immuno-oncology (116)
Indications (209)
Infectious disease (3220)
Inflammatory bowel disease (226)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (303)
Interviews (467)
IPO (15155)
IRA (58)
Job creations (3395)
Job search strategy (1722)
JPM (70)
Kidney cancer (22)
Labor market (110)
Layoffs (663)
Leadership (51)
Legal (7563)
Liver cancer (111)
Longevity (27)
Lung cancer (876)
Lymphoma (477)
Machine learning (61)
Management (54)
Manufacturing (1095)
Marketing (1)
MASH (221)
Medical affairs (1)
Medical device (12449)
Medtech (12587)
Mergers & acquisitions (16657)
Metabolic disorders (1721)
mRNA (255)
Multiple sclerosis (183)
NASH (23)
Neurodegenerative disease (468)
Neuropsychiatric disorders (124)
Neuroscience (3508)
Neurotech (2)
NextGen: Class of 2026 (5681)
Non-profit (4130)
Now hiring (47)
Obesity (837)
Opinion (328)
Ovarian cancer (245)
Pain (252)
Pancreatic cancer (361)
Parkinson's disease (389)
Partnered (31)
Patents (626)
Patient recruitment (747)
Peanut (68)
People (51309)
Pharmaceutical (48)
Pharmacy benefit managers (36)
Phase 1 (21405)
Phase 2 (29962)
Phase 3 (23204)
Pipeline (9401)
Policy (391)
Postmarket research (2628)
Preclinical (9097)
Press Release (37)
Prostate cancer (352)
Psychedelics (68)
Radiopharmaceuticals (366)
Rare diseases (1231)
Real estate (4942)
Recruiting (65)
Regulatory (25852)
Reports (49)
Research institute (2462)
Resumes & cover letters (411)
Rett syndrome (43)
RNA editing (29)
RSV (93)
Schizophrenia (192)
Series A (287)
Series B (219)
Service/supplier (9)
Sickle cell disease (121)
Special edition (30)
Spinal muscular atrophy (174)
Sponsored (53)
Startups (3164)
State (1)
Stomach cancer (21)
Supply chain (140)
Tariffs (104)
The Weekly (130)
Vaccines (1265)
Venture capital (133)
Weight loss (582)
Women's health (128)
Worklife (24)
Date
Last 7 days (492)
Last 30 days (2494)
Last 365 days (30022)
2026 (15217)
2025 (30080)
2024 (33766)
2023 (37945)
2022 (48572)
2021 (52300)
2020 (49617)
2019 (41266)
2018 (31192)
2017 (30729)
2016 (29411)
2015 (32877)
2014 (26168)
2013 (21822)
2012 (23245)
2011 (23518)
2010 (22038)
Location
Africa (796)
Alabama (82)
Alaska (6)
Arizona (311)
Arkansas (14)
Asia (38197)
Australia (6904)
California (13401)
Canada (3375)
China (1393)
Colorado (527)
Connecticut (611)
Delaware (409)
Europe (92058)
Florida (2018)
Georgia (404)
Hawaii (4)
Idaho (53)
Illinois (1064)
India (88)
Indiana (596)
Iowa (25)
Japan (574)
Kansas (125)
Kentucky (48)
Louisiana (41)
Maine (82)
Maryland (1629)
Massachusetts (9733)
Michigan (317)
Minnesota (710)
Mississippi (5)
Missouri (140)
Montana (22)
Nebraska (25)
Nevada (138)
New Hampshire (70)
New Jersey (3556)
New Mexico (23)
New York (3527)
North Carolina (1715)
North Dakota (8)
Northern California (6846)
Ohio (394)
Oklahoma (19)
Oregon (37)
Pennsylvania (2581)
Puerto Rico (27)
Rhode Island (38)
South America (1135)
South Carolina (84)
South Dakota (2)
Southern California (5252)
Tennessee (211)
Texas (2264)
United States (47224)
Utah (345)
Vermont (1)
Virginia (326)
Washington D.C. (78)
Washington State (1078)
West Virginia (4)
Wisconsin (142)
Wyoming (1)
645,457 Results for "texas children s cancer centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring
Cancer Research UK’s Centre for Drug Development is using TrialAssure LINK AI to support medical writing in CRUK-sponsored studies
June 18, 2026
·
1 min read
Press Releases
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference
June 15, 2026
·
4 min read
Press Releases
Tri Delta Reaches $25M Milestone for St. Jude Children’s Research Hospital
June 15, 2026
·
3 min read
Press Releases
Texas Children’s Researcher Awarded Grant to Advance New Ways to Prevent and Treat Alzheimer’s Disease
March 25, 2026
·
4 min read
Press Releases
Picard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children’s Hospital
April 15, 2026
·
5 min read
FDA
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
Fallout from the resignation of FDA Commissioner Marty Makary continues as several other senior regulators are removed from their posts; pharma’s top paid CEOs make up to 358 times more than their employees; Revolution Medicine’s pancreatic cancer results highlight movement in the deadly disease space; more.
May 20, 2026
·
1 min read
·
Jef Akst
Press Releases
Constantiam Biosciences and Cincinnati Children’s Collaborate to Accelerate First-in-Class Neuronopathic Gaucher Disease Therapies
June 19, 2026
·
2 min read
Pancreatic cancer
‘WOW!’: RevMed and Tango’s pancreatic cancer combo achieves 92% response
After Revolution Medicine’s groundbreaking data drop in April, its Tango-partnered combination approach has demonstrated what analysts called “unprecedented” results for 12 patients with pancreatic cancer, teeing up a late-stage study.
June 8, 2026
·
2 min read
·
Gabrielle Masson
China
Pfizer bets up to $10.5B in 12-candidate cancer collab with China’s Innovent
Pfizer continues its dealmaking spree by striking a back-heavy partnership with China’s Innovent Biologics to assemble a pipeline of antibody-based therapies for cancer.
May 29, 2026
·
2 min read
·
Tristan Manalac
Pancreatic cancer
Can Revolution’s ‘miracle’ pancreatic cancer drug be topped? Immuneering, Actuate say yes
Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve on that result with increased tolerability—and more time for patients.
May 18, 2026
·
7 min read
·
Heather McKenzie
1 of 64,546
Next
